SITUATION OF USING DRUGS FOR GOUT TREATMENT OF OUTPATIENTS

Abstract

Objective: To describe the current Situation of using gout drugs on outpatients at Can Tho City General Hospital. Subjects and methods: retrospective and longitudinal study,  based on outpatient prescriptions at Can Tho City General Hospital from 06/2019 - 12/2019. Results: 100% of patients were prescribed alopurinol for the purpose of controlling uric acid level, bringing blood uric acid to the “target” level. In addition, 34.52% of patients used colchicin and 7.14% of patients used meloxicam in the treatment of acute gout attacks. Outpatients were treated with a single initial regimen (accounting for 80.95%), the majority of patients used alopurinol alone (accounting for 92.65%). The main reason for changing the regimen was that the clinical symptoms have improved (accounting for 69.57%). The use of gout drugs effectively reduces blood uric acid levels of outpatients. Number of patients reaching treatment goals after 3 months of continuous monitoring reached a relatively high rate (accounting for 61.90%). Conclusion: Gout outpatient treatment mainly used monotherapy with high rate of alopurinol alone. The effectiveness of uric aicd reduction and reaching the goal of treatment on outpatient patients was high.